Evidence map›Paper›PMID 21460487›Full record

ArticleInfection control and hospital epidemiology2011

Development and validation of a Clostridium difficile infection risk prediction model.

Erik R Dubberke, Yan Yan, Kimberly A Reske, Anne M Butler, Joshua Doherty, Victor Pham, Victoria J Fraser

Abstract readValidation Study
In one paragraph

Article in Infection control and hospital epidemiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Article
  3. Predicting positiveHeliyon · 2025
    Article
  4. Curbing inappropriateAntimicrobial stewardship & healthcare epidemiology : ASHE · 2025
    Article
  5. Article
  6. Article
  7. Strategies to preventInfection control and hospital epidemiology · 2023
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Evaluation of a risk score to predict futureHuman vaccines & immunotherapeutics · 2019
    Observational
  16. Review
  17. Learning Credible Models.KDD : proceedings. International Conference on Knowledge Discovery & Data Mining · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Erik R DubberkeWashington University School of Medicine, St. Louis, Missouri, USA. edubberk@dom.wustl.edu
Yan Yan
Kimberly A Reske
Anne M Butler
Joshua Doherty
Victor Pham
Victoria J Fraser

Funding

Washington University Institute of Clinical and Translational SciencesKL2TR000450 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$8.8M
VALIDATION AND MODELING OF A C. DIFFICILE INFECTION RISK PREDICTION INDEXR21NR011362 · NINR · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2010
$416k
C. DIFFICILE DISEASE IN STEM CELL TRANSPLANT RECIPIENTSK23AI065806 · NIAID · WASHINGTON UNIVERSITY · PI DUBBERKE, ERIK R · 2009 to 2011
$374k
NCATS NIH HHS KL2 TR000450NIAID NIH HHS 1K23AI065806-01A2NIAID NIH HHS K23 AI065806NINR NIH HHS 1-R21-NR011362-01NINR NIH HHS R21 NR011362PHS HHS 1U01C1000333-01PHS HHS UR8/CCU715087-06/1
6 · The paper itself

Abstract

objectiveTo develop and validate a risk prediction model that could identify patients at high risk for Clostridium difficile infection (CDI) before they develop disease. DESIGN AND

settingRetrospective cohort study in a tertiary care medical center. PATIENTS: Patients admitted to the hospital for at least 48 hours during the calendar year 2003.

methodsData were collected electronically from the hospital's Medical Informatics database and analyzed with logistic regression to determine variables that best predicted patients' risk for development of CDI. Model discrimination and calibration were calculated. The model was bootstrapped 500 times to validate the predictive accuracy. A receiver operating characteristic curve was calculated to evaluate potential risk cutoffs.

resultsA total of 35,350 admitted patients, including 329 with CDI, were studied. Variables in the risk prediction model were age, CDI pressure, times admitted to hospital in the previous 60 days, modified Acute Physiology Score, days of treatment with high-risk antibiotics, whether albumin level was low, admission to an intensive care unit, and receipt of laxatives, gastric acid suppressors, or antimotility drugs. The calibration and discrimination of the model were very good to excellent (C index, 0.88; Brier score, 0.009).

conclusionsThe CDI risk prediction model performed well. Further study is needed to determine whether it could be used in a clinical setting to prevent CDI-associated outcomes and reduce costs.

Indexed as

Clostridioides difficileAdolescentAdultAgedAged, 80 and overAge FactorsAnti-Bacterial AgentsAnti-Ulcer AgentsChildClostridium InfectionsFemaleHospitalizationHumansLaxativesLogistic ModelsMaleAnti-Bacterial AgentsAnti-Ulcer AgentsLaxatives

Identifiers

PMID21460487
PMCPMC3649761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.